Taken together, our findings demonstrate that early, ChP targeted NKCC1 OE has a sustained and broad impact on specific volumetric and biophysical parameters of the intracranial space with potential therapeutic applications to hydrocephalus. Here, SLC12A2 is linked to Hydrocephalus.